首页> 外文期刊>Oncogene >Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis
【24h】

Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis

机译:Netrin-1和依赖受体DCC在癌细胞侵袭,肿瘤生长和转移中的相反作用

获取原文
           

摘要

Deleted in colon cancer (DCC) and UNC5 function as netrin dependence receptors by inducing apoptosis in the absence of their ligand and accordingly were recently designated as putative conditional tumor suppressors. Herein, we determined whether netrin-1 and its receptors are implicated in cancer cell invasion and tumor progression. Expression of DCC, UNC5 and adenosine A2B-receptors (A2B-Rs) was investigated by reverse transcription polymerase chain reaction in human colon cancer cells. The impact of DCC restitution and netrin-1 was evaluated on collagen type I invasion, tumor growth and metastasis in nude mice, cancer cell survival and gene expression profiling. Flow cytometry, poly(ADP-ribose)polymerase-1 and caspase-8 activation were used to evaluate the impact of DCC on cell death. Both netrin-1 and A2B-R activation induced the invasive phenotype through the Rho–Rho kinase axis in DCC-deficient human colorectal cancer cells. Restitution of wild-type DCC blocked invasion induced by netrin-1, A2B-R agonist and other agents. Ectopic expression of netrin-1 led to increased growth of human colon tumor xenografts in athymic mice. Conversely, introduction of wt-DCC in kidney MDCKts.src-ggl cells strongly inhibited metastasis in lymph nodes and lungs and increased sensitivity to apoptosis in hypoxia. DNA microarrays revealed that netrin and DCC had common and divergent impacts on gene expression linked to cell cycle, survival, surface signaling and adhesion. Our findings underscore that netrin is a potent invasion and tumor growth-promoting agent and that DCC is a metastasis suppressor gene targeting both proinvasive and survival pathways in a cumulative manner.
机译:在结肠癌中缺失的(DCC)和UNC5通过在不存在配体的情况下诱导细胞凋亡而充当netrin依赖性受体,因此最近被指定为假定的条件性肿瘤抑制剂。在本文中,我们确定了netrin-1及其受体是否与癌细胞侵袭和肿瘤进展有关。通过逆转录聚合酶链反应研究了DCC,UNC5和腺苷A2B受体(A2B-Rs)在人结肠癌细胞中的表达。评估了DCC恢复和netrin-1对I型胶原入侵,裸鼠肿瘤生长和转移,癌细胞存活和基因表达谱的影响。流式细胞仪,聚(ADP-核糖)聚合酶-1和caspase-8激活被用来评估DCC对细胞死亡的影响。 netrin-1和A2B-R激活均可通过DCC缺陷型人类结直肠癌细胞中的Rho-Rho激酶轴诱导侵袭性表型。恢复野生型DCC可阻止netrin-1,A2B-R激动剂和其他药物诱导的侵袭。 netrin-1的异位表达导致无胸腺小鼠中人类结肠肿瘤异种移植物的生长增加。相反,在肾脏MDCKts.src-ggl细胞中引入wt-DCC强烈抑制了淋巴结和肺部的转移,并增加了对缺氧细胞凋亡的敏感性。 DNA芯片显示,netrin和DCC对基因表达具有共同且不同的影响,这些影响与细胞周期,存活,表面信号传导和粘附有关。我们的发现强调,netrin是一种有效的侵袭和肿瘤生长促进剂,而DCC是一种以累积方式靶向侵袭和存活途径的转移抑制基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号